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Abstract
Epilepsy is a common disabling disease with complex, multifactorial genetic and environ-
mental etiology. The small fraction of epilepsies subject to Mendelian inheritance offers key
insight into epilepsy disease mechanisms; and pathologies brought on by mutations in a
single gene can point the way to generalizable therapeutic strategies. Mutations in the
PRICKLE genes can cause seizures in humans, zebrafish, mice, and flies, suggesting the
seizure-suppression pathway is evolutionarily conserved. This pathway has never been tar-
geted for novel anti-seizure treatments. Here, the mammalian PRICKLE-interactome was
defined, identifying prickle-interacting proteins that localize to synapses and a novel inter-
acting partner, USP9X, a substrate-specific de-ubiquitinase. PRICKLE and USP9X interact
through their carboxy-termini; and USP9X de-ubiquitinates PRICKLE, protecting it from pro-
teasomal degradation. In forebrain neurons of mice, USP9X deficiency reduced levels of
Prickle2 protein. Genetic analysis suggests the same pathway regulates Prickle-mediated
seizures. The seizure phenotype was suppressed in pricklemutant flies by the small-mole-
cule USP9X inhibitor, Degrasyn/WP1130, or by reducing the dose of fat facets a USP9X
orthologue. USP9Xmutations were identified by resequencing a cohort of patients with
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epileptic encephalopathy, one patient harbored a de novomissense mutation and another
a novel coding mutation. Both USP9X variants were outside the PRICKLE-interacting do-
main. These findings demonstrate that USP9X inhibition can suppress prickle-mediated sei-
zure activity, and that USP9X variants may predispose to seizures. These studies point to a
new target for anti-seizure therapy and illustrate the translational power of studying dis-
eases in species across the evolutionary spectrum.
Author Summary
Epilepsy is a common disabling disorder characterized by seizures with complex genetic
and environmental components. The absence of a definitive pathophysiology for epilepsy
stymies the development of effective treatment strategies. In a small fraction of epilepsy
cases however, single gene mutations may illuminate seizure-causing mechanisms, which
may open the door to the discovery of broader, more effective therapeutic strategies. We
have previously shown that disruption of Prickle genes in multiple species including hu-
mans, results in a predisposition to seizures. Those findings support Prickle in a seizure-
preventing role and presents a possible anti-seizure therapeutic target. We identified the
deubiquitinase Usp9x (ubiquitin-specific peptidase 9 X-linked) as a new Prickle binding
partner which stabilized Prickle by preventing its degradation. In mice lacking the Usp9x
protein in their forebrains, Prickle2 was barely detectable. In seizure-prone pricklemutant
Drosophila, reducing fat facets (Drosophila usp9x) genetically or by a small-molecule
usp9x inhibitor (Degrasyn/WP1130) suppressed the seizures. We also found 2 epilepsy pa-
tients harboring mutations in USP9X. Our findings demonstrate that inhibition of Usp9x
can arrest prickle-mediated seizures, and variations in USP9Xmay predispose to seizures.
From these studies, we have elucidated a seizure-inducing mechanism, identified a poten-
tial anti-seizure target, and a potential anti-seizure drug.
Introduction
Mutations in the PRICKLE genes can cause seizures in humans, zebrafish, mice, and flies, sug-
gesting the seizure-suppression pathway is evolutionarily conserved.[1–5]. Prickle binding
partners have been studied extensively only in either non-neuronal vertebrate cell lines or non-
neuronal tissues in the fly. (In both cases Prickles were shown to bind other WNT/PCP pro-
teins.[6, 7]) Such targeted approaches showed Prickles interact with REST, some kinases (in-
cluding BCR), and post-synaptic density proteins, including TANC1 and TANC2.[4, 6] To
identify neuronal proteins that bind Prickles, recent work by our group and others showed
PRICKLE1 also binds to Smurf1 (a ubiquitin ligase),[8] and Synapsin1, (a gene implicated in
both epilepsy and autism)[1]; and PRICKLE2 also binds PSD-95 and p150Glued.[9] To identify
other PRICKLE binding partners in neuronal-like cells, we used mass spectroscopy: a more
global, unbiased approach.
Results
The interaction was monitored in a subclone of rat pheochromocytoma PC12 cells which, when
treated with Nerve Growth Factor (NGF), assume a sympathetic neuron-like phenotype.[10]
Clonal PC12 lines that overexpressed doxycycline-inducible GFP, GFP-PRICKLE1 (GFP-PK1),
or GFP-PRICKLE2 (GFP-PK2) were produced (S1 Fig). Protein complexes immunoprecipitated
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with anti-GFP beads from whole-cell lysates (S1C Fig) were analyzed by mass spectrometry (IP-
MS, S2 Fig).[1] Prickle interactors were considered candidates only if they recovered>10 peptide
matches with both GFP-PRICKLE1 and GFP-PRICKLE2, but not with GFP alone (S1 Table).
This dataset recovered both known Prickle-interactors (e.g., Tanc2, and Bcr[6]) and novel Prickle
interactors, including Usp9x,[11–15] a substrate-specific de-ubiquitinase. The putative Prickle-
Usp9x interaction was of particular interest because Usp9x physically interacts with Smurf1 (to
date, one of the few Prickle interactors identified in neural tissues[13] and both are implicated in
neurite extension).[16] Moreover, since ubiquitination plays a role in cancer pathogenesis, a vari-
ety of reagents that modulate this system are already commercially available and in clinical trials.
[17] The combination of previously identified Prickle-interacting partners with the present stud-
ies are depicted in the Prickle-interactome (Fig. 1) that we utilize to identify new seizure-
modifying targets.
To evaluate further USP9X as a PRICKLE binding partner, coimmunoprecipitation (co-IP)
assays were carried out in the original PC12 GFP, GFP-PRICKLE1, and GFP-PRICKLE2 cells
lines, utilizing Tanc2 and Bcr as positive controls. To detect the respective endogenous pro-
teins, GFP-immunoprecipitates from the differentiated cell lines were immunoblotted with
anti-BCR, anti-TANC2, and anti-USP9X. Fig. 2A demonstrates interaction by all three pro-
teins in GFP-PRICKLE1 and GFP-PRICKLE2 immunoprecipitates. To validate this interac-
tion, co-IPs were carried out in a different cell line. Flag-tagged PRICKLE1 and PRICKLE2
were immunoprecipitated from human embryonic kidney (HEK293T) cells and subjected to
anti-USP9XWestern blot analysis; Fig. 2B shows both PRICKLE1 and PRICKLE2 interact
with endogenous USP9X in HEK293T cells.
To map the PRICKLE1-USP9X interacting domain, recombinant vectors expressing full-
length, N-terminal or C-terminal portions of PRICKLE1 (schematic diagrams in Fig. 2C, D)
were transfected into HEK293T cells and immunoprecipitated via the Flag tag. Fig. 2C showed
that endogenous USP9X interacted specifically with the PRICKLE1 C-terminus. On the other
hand, BCR interacted with the N-terminus, a region that includes the PET/LIM domains, pre-
viously known to mediate Prickle1 protein-protein interactions.[20] The same approach de-
fined the PRICKLE2-USP9X interacting domain. As with PRICKLE1, while the interaction
with BCR mapped to the N-terminus, the PRICKLE2–USP9X interaction mapped to the C-ter-
minus of PRICKLE2 (Fig. 2D).
SMURF1 and USP9X are known to physically interact via the second WW domain of
SMURF1 and the USP9X carboxyl terminus (a fragment named C2)[13] so, hypothetically, the
PRICKLE interaction should also map to the same region. To test this, a PRICKLE1 or PRICK-
LE2 c-terminal fragment was expressed with one of two flag-tagged Usp9x deletion fragments:
C1Usp9x (amino acids 1216–2107) and C2Usp9x (the carboxy terminal amino acids 2102–
2560; Fig. 3A). Complexes were immunoprecipitated via the Flag tag. Fig. 3A shows that the
PRICKLE1 and PRICKLE2 interactions also map to the carboxyl terminus of Usp9x (C2). The
C-terminal end of both PRICKLEs and USP9X are therefore crucial for the PRICKLE-
USP9X interaction.
PRICKLE is ubiquitinated by the E3 ligase, SMURF2, which promotes PRICKLE degrada-
tion and turnover in HEK293T cells.[8] Ubiquitin tags from mono- and polyubiquitinated pro-
teins can be removed by the C1-terminal catalytic motif of USP9X deubiquitinase.[12, 13, 21–
23] We postulated the physical interaction between the PRICKLEs and USP9X might indicate
that PRICKLE was a USP9X substrate, and that USP9X deubiquitinates and stabilizes both
PRICKLE1 and PRICKLE2. To test this idea, PRICKLE substrates were monitored in USP9X
deubiquitination assays.
In previous studies, overexpression of the C1Usp9x catalytic fragment alone was sufficient to
deubiquitinate USP9X substrates.[23] Accordingly, the robust ubiquitination of Flag-PRICKLE1
USP9X Regulates Seizures
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(Fig. 3B, C) was antagonized by overexpression of C1Usp9x; and PRICKLE was stabilized
(Fig. 3). Similar results were obtained with full-length USP9X (S3 Fig). In the presence of the
proteasomal inhibitor LLNL (N-acetyl-L-leucyl-L-leucyl-L-norleucinal), polyubiquitinated
PRICKLE1 or PRICKLE2 accumulated, indicating that degradation of ubiquitinated PRICKLE is
mediated by the proteasome as opposed to the lysosome (S3 Fig). To determine if a Prickle-
Usp9x interaction has a functional effect in mice, we generated mice with deletion of Usp9x in
the forebrain (Emx1-Cre/Usp9x loxtemp)[12] and examined expression of Prickle2. In the ab-
sence of Usp9x in 4-week old mice, Prickle2 was not detected in the cortex, CA1 region of the
hippocampus, and dentate gyrus (Fig. 3D). Taken together, these data suggest that Prickles are
novel Usp9x substrates.
Fig 1. Prickle interactome.We combined findings from our proteomics interaction experiment and public databases to generate a prickle interactome. We
used the MetaCore (MetaCore, GeneGO Inc., St. Joseph, MI, USA) networking function and String database 9.1 to curate interaction maps of the proteins
identified. Information for identified interactions is obtained from several sources including but not limited to genomic context, database imports (PPI and
pathway databases), high-throughput experiments, co-expression, and text mining. We uploaded our lists of proteins from LC-MS/MS into the software
programs and exported the networks into Cytoscape 2.7.0 for manipulation of the network appearance. (Nodes, circles; Edges, lines). Red lines correspond
to interactions observed by our labs using yeast-2-hybrid and IP-MS approaches. The extended interactome was generated as we have previously
described. [1, 6–9, 18, 19] Prickle1 and Prickle2 interact with known synaptic proteins. The interaction with USP9X is novel.
doi:10.1371/journal.pgen.1005022.g001
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Genetic analysis was used to determine if Prickle and Usp9x interact genetically in fruit
flies. We reduced the dosage of the USP9X orthologue (fat facets, or faf) in the context of a
pricklemutation (pksple/+) which on its own promotes both behavioral and electrophysiologic
seizure activity.[3, 5] Three separate loss-of-function faf alleles were used to create transhetero-
zygotes, which were then assayed with the bang sensitivity behavioral assay to assess recovery
time from seizure activity. For every faf allele used, reducing its level suppressed the seizures in
the context of the pksple/+ flies (Fig. 4A-C). Adding the USP9X small-molecule inhibitor Degra-
syn/WP1130[24] to the fly food inhibited seizure activity in pksple homozygous flies (Fig. 4D)
using a “fly flip” assay (see Materials and Methods).
The demonstration that pharmacologic treatment with a USP9X inhibitor suppresses sei-
zures in conjunction with genetic seizure suppression utilizing fly USP9X orthologue mutations
suggests that USP9Xmutations could protect humans from seizures. In contrast to this sugges-
tion, in humans, USP9X has been postulated to be an epilepsy candidate gene. USP9X is X-
linked; and in males has been associated with both autism spectrum disorder (ASD) and
Fig 2. PRICKLE interacts with USP9X via its carboxyl terminal. A. PRICKLE1 and PRICKLE2 interact with endogenous Bcr, Tanc2, and Usp9x in NGF-
differentiated PC12 cells. GFP immunoprecipitates from stable lines expressing GFP, GFP-PRICKLE1 or GFP-PRICKLE2 confirm that PRICKLE interacts
with Bcr, Usp9x and Tanc2. B. Flag immunoprecipitates, from HEK293T cells overexpressing flag-tagged PRICKLE1 or PRICKLE2, show endogenous
USP9X physically interacts with PRICKLE. C, D. Schematic of PRICKLE1(C) and PRICKLE2(D) constructs. Flag-immunoprecipitates from HEK293T cells
overexpressing the indicated constructs were analyzed by anti-USP9XWestern blotting. Both PRICKLE 1 and 2 interact with USP9X via their C-termini while
BCR binding mapped to their N-termini.
doi:10.1371/journal.pgen.1005022.g002
USP9X Regulates Seizures
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intellectual disability (which are frequently co-morbid with epilepsy). Moreover, mice with
Usp9x-deficient neurons develop abnormal neuronal connectivity.[12, 14, 25, 26] A similar ap-
parent discrepancy has been observed in the case of the SCN1A gene (which codes for the
NAV1.1 channel) and its fly homologue para. Here, the great majority of 68 different muta-
tions in para suppress seizures in the fly,[27–31] yet human SCN1Amutations are associated
with severe epileptic encephalopathies, febrile seizure syndromes, and Dravet syndrome. Re-
cent studies demonstrated that although loss-of-function para alleles suppress seizures, a few
recently identified gain-of-function para alleles (e.g., parabss1) actually cause seizures in the fly.
[27] Accordingly, many of the most severe human SCN1Amutations are missense or trunca-
tion, gain-of-function alleles (see web resources).[32]
To assess if USP9X coding variants might be associated with human seizures, the USP9X
gene was resequenced in 284 male patients with epileptic encephalopathy. One male patient,
T17133, presented with epileptic encephalopathy and was found to carry a de novo USP9Xmu-
tation (c.3034T>C, p.Ser1012Pro) at a highly conserved residue (GERP 5.62) that was
Fig 3. USP9X stabilizes PRICKLE in HEK293T cells and the mouse brain. A. Flag-immunoprecipitates from HEK293T cells overexpressing the indicated
constructs show PRICKLE and USP9X interact via their carboxyl termini.B, C. USP9X deubiquitinates PRICKLE. Immunoprecipitates from HEK293T cells
overexpressing the indicated constructs show PRICKLE ubiquitination in the presence of HA-Ubiquitin and deubiquitination/stabilization by Usp9x. IP
(immunoprecipitates), IN (input).D. Loss of Usp9X affects Prickle2 (green) expression. Deletion of Usp9x results in decreased Prickle2 expression in the
cortex (I), CA1 (II) and dentate gyrus (III) of 4-week old mice when compared to controls (IV, V, VI). n = 2. Scale bar:20μM. Nuclear stain = DAPI.
doi:10.1371/journal.pgen.1005022.g003
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predicted to be possibly damaging by PolyPhen (0.898). Another patient with infantile spasms
(parental genotypes unavailable) harbored variant (T2587c.5669G>A, p.Gly1890Glu) a rare
missense variant. Both mutations lie outside the identified Prickle-binding domain. The
USP9X pSer1012 is very close to the Ubiquitin-like (UBL) domain; and the USP9X Gly1890 is
in UCH (Ubiquitincarboxyl-terminal hydrolase) domain, just eleven amino acids from the pro-
ton acceptor in the active site, and in between the catalytic Cys and His motifs that form the
catalytic domain, suggesting that both mutations likely alter normal USP9X function. Rare
coding variants were sought in the cohort of 284 males with epilepsy and the male exomes in
the NHLBI exome variant server EVS (see web resources) in a one-tailed Chi-squared analysis.
For the combined African American and European American cohorts, we found a statistical as-
sociation (p = 0.0350) between USP9X rare coding variants and epilepsy (S2 Table). This fur-
ther supports the assertion that USP9Xmay be a novel epilepsy gene.
Discussion
Our studies suggest USP9X-mediated de-ubiquitination stabilizes PRICKLE proteins in the
nervous system. These results are consistent with results in other tissues, where faf RNAi
Fig 4. Genetic and pharmacological suppression of the seizure phenotype in prickle mutant flies. (A–C) Reducing faf dosage with three separate
loss-of-function alleles ((fafB3, fafBX3, fafBX4; graphs A, B and C, respectively) suppresses the pksple-mediated seizure phenotype detected by the modified
bang sensitivity assay. Six vials per genotype were assayed.D. Inhibition of faf activity with Degrasyn suppresses pksple-mediated seizure activity detected
using the “fly flip” assay. Three vials per genotype were assayed. Note: +/+ = Oregon-R control flies; sple = pksple; sple/faf = pksple/+; +/faf. * = p< 0.05. Error
bars = standard error. Each vial contains 5 males and 5 females.
doi:10.1371/journal.pgen.1005022.g004
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reduced Prickle levels in Drosophila apicolateral junctions,[33] as well as studies showing
USP9X stabilizes several proteins involved in various aspects of neuronal development and
cancer.[12] Notably, USP9X was shown to stabilize oncoproteins (e.g., MCL-1 and p53), spark-
ing interest in modulating USP9X in tumors, with promising results.[24]
Here, we showed that human USP9Xmutations are associated with epilepsy. Our data cor-
roborate other evidence showing USP9Xmutations in males with co-morbid epilepsy condi-
tions (e.g., intellectual disability and ASD). In addition to USP9X, several other members of
our identified Prickle-interactome were already implicated in seizures, intellectual disability,
and ASD. (For example, a TANC2 variant in a patient with intellectual disability and febrile sei-
zures[34] and in a patient with ASD,[35] and a SMURF1 variant in a patient with epileptic en-
cephalopathy).[36]
PRICKLEmutant humans, mice, zebrafish, and Drosophila all exhibit seizures.[3, 5] In flies,
the prickle seizure phenotype can be genetically suppressed by reducing Faf (creating transhe-
terozygotes) or pharmacologically rescued by treating pksple mutants with Degrasyn/WP1130.
Although USP9X is genetically associated with seizures in both flies and humans, mutations
are seizure-protective in the flies but seizure-inducing in humans. This opposing effect is likely
because the identified human USP9Xmutations are all protein-changing mutations that reside
outside of the Prickle-interaction domain whereas the fly fafmutations that suppress seizures
are all amorphic alleles. This suggests that, for USP9X, complete loss of function may have a
different phenotype than protein coding alleles. Before our study, neither USP9X inhibition
nor stimulation was identified as a potential anti-seizure pathway. Yet, given the evolutionarily
conservation of the Prickle-pathway, our results suggest Degrasyn/WP1130 and other USP9X-
modulating molecules should be pursued as novel therapeutic agents for patients suffering
from seizures.
Materials and Methods
Antibodies and antibody-conjugated agarose beads
The antibodies employed were rabbit polyclonal anti-BCR (Santa Cruz), rabbit polyclonal anti-
TANC2 (Bethyl), polyclonal rabbit-anti USP9X (Abcam), mouse monoclonal anti-β-actin
(Sigma), mouse monoclonal anti-Flag (Sigma), rat monoclonal anti-HA-peroxidase (Roche),
rabbit polyclonal anti-dsRed from Clontech (detects mCherry) mouse monoclonal anti-Myc
(Santa Cruz), rabbit polyclonal anti-GFP (Santa Cruz). Anti-rabbit and anti-mouse horseradish
peroxidase (HRP)-conjugated secondary antibodies (Thermo Scientific). The agarose anti-
body-conjugated beads were protein A/G beads (Pierce), anti-Flag (Santa Cruz), and anti-GFP
Plasmids
Flag-PRICKLE1 plasmid was as previously described.[4] The N-terminus of PRICKLE1 (aa 1
to 313) and the C-terminus of PRICKLE1 (aa 314 to 831) were each Flag-tagged on the C-ter-
minus and cloned into EcoRI (5’) and KpnI (3’) restriction sites of the pcDNA3.1 vector. The
N-terminus (aa 1 to 317) and C-terminus of PRICKLE2 (aa 318 to 844) were also Flag-tagged
on the C-termini and cloned into EcoRI (5’) and KpnI (3’) restriction sites of the same vector.
Using previous studies as a guide, we cloned deletion constructs of murine Usp9x.[23]
C1Usp9x aa 1216–2107 (with the catalytic domain) and C2Usp9x aa 2102–2560 (the carboxyl
terminus) were cloned into the BamH1 and BSpe1 restriction sites of the pmCherryC1 plasmid
(Clontech). The previously described HA-UbiquitinC plasmids were kindly gifted by Pedro
Gonzalez-Alegre (University of Iowa, Iowa City).
USP9X Regulates Seizures
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Tissue culture
HEK293T[37] cells were cultured in DMEM (Dulbecco’s modified eagle medium; Gibco) sup-
plemented with 10% FBS (fetal bovine serum) and 1% penicillin-streptomycin (Gibco). PC12
cells were cultured in collagen-coated plates in RPMI (Roswell Park Memorial Institute medi-
um) supplemented with 5% FBS, 10% HS (horse serum), 1% penicillin-streptomycin, hygro-
mycin (100μg/ml), and blasticidin (5μg/ml). Cells were maintained in a humidified 37°C, 5%
CO2 incubator. Transgene expression and differentiation were induced by 1.5μg/ml dox and
100 ng/ml NGF treatment in low serum RPMI medium (2% HS, 1% FBS) respectively.
Generation of PC12 inducible lines expressing GFP, GFP-PRICKLE1 or
GFP-PRICKLE2
PC12 neuronal-like cell lines are used as a model system for investigating neuronal differentia-
tion in culture.[10] As reported before, a PC6-3 (sub-clone of PC12 cells) clonal line, stably ex-
pressing the tet-repressor protein pcDNA6/TR (PC6-3/TR), was generously provided by Pedro
Gonzalez-Alegre (University of Iowa, Iowa City).[1] Clonal cell lines inducibly expressing
GFP, GFP-PRICKLE1 or GFP-PRICKLE2 were generated as previously described.[1, 38] GFP,
GFP-PRICKLE1, and GFP-PRICKLE2 cDNAs were cloned into EcoRI and XhoI restriction
sites of pcDNA5 TO (Invitrogen). Plasmids were transfected into the PC6-3/TR cells, with
Lipofectamine 2000 (Qiagen), according to the manufacturer’s instructions. Clonal cells stably
expressing the transgenes were selected (medium supplemented with hygromycin at 100μg/ml)
and blasticidin (5μg/ml) and screened for doxycycline inducibility by fluorescence microscopy
and anti-GFPWestern blots.
Western blots
Dox-treated and untreated PC12 cells expressing GFP, GFP-PRICKLE1, or GFP-PRICKLE2
were lysed in ice-cold, NET-100 buffer (Tris 50mM, NaCl 100mM, EDTA 5mM supplemented
with protease inhibitor (1X EDTA-free Complete Mini-tabs protease inhibitor cocktail from
Roche). Equal amounts of proteins were resolved by sodium dodecyl sulfate-acrylamide gel
electrophoresis (SDS-PAGE) in 4–20% acrylamide gels (pre-cast gels, Biorad) and transferred
onto a Polyvinylidene fluoride (PVDF) membrane for 3 hours at 0.30 Amps. The membrane
was blocked in 5% non-fat milk for 2 hours at room temperature followed by incubation in
anti-GFP antibody at 1:1000 dilution overnight at 4°C. The membrane was then washed in
TBST (Tris-buffered saline with Tween-20) at room temperature, followed by incubation in
(horseradish) HRP-conjugated goat-anti-rabbit antibody (1:10 000) at room temperature for 2
hours. The blots were developed using ECL detection kit (Thermo Scientific) after washing, as
per the manufacturer’s instructions. Signals were captured on x-ray films.
Immunoprecipitation
Immunoprecipitations were carried out as previously described.[1, 38] Differentiated, dox-
treated GFP, GFP-PRICKLE1, and GFP-PRICKLE2 PC12 cell lines were lysed in ice-cold
NET-100 buffer supplemented with a protease inhibitor. Lysates were immunoprecipitated
overnight with GFP-conjugated agarose beads after 1 hour of pre-clearing in A/G agarose
beads. After 5 X 5 minute washes in NET-100 buffer, immunoprecipitates were eluted in 2X
Laemmli buffer at 100°C for 5 minutes. Equal volumes of immunoprecipitates were resolved by
SDG-PAGE in 4–20% acrylamide gels and then silver-stained.
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Silver staining
Following electrophoresis, a gel with resolved GFP immunoprecipitates was incubated in fixing
solution (50% methanol, 10% acetic acid) for 30 minutes at room temperature and washed
overnight in water. The gel was then incubated in 100mL of sodium thiosulphate solution
(0.33g sodium thiosulphate/ 1L water) for 120 seconds, followed by 3 X 30-second washes in
water. This was followed by incubation in silver nitrate solution (0.2g silver nitrate/100mL
water) for 30 minutes. The gel was then washed in distilled water for 3 X 60 seconds, and then
incubated in developing solution (3g sodium carbonate, 50μl formaldehyde, 2mL sodium thio-
sulphate solution, 93mL water) until proteins bands became visible. The stop solution (7g
EDTA/500ML water) was added to the gel and shaken for 10 minutes to stop further
development.
Mass spectrometry LC-MS/MS
This was carried out as previously described.[1]
SDS-PAGE. 20 μL of clarified, soluble GFP, GFP-PRICKLE1, and GFP-PRICKLE2 immu-
noprecipitates were added to denaturing, SDS-PAGE, loading buffer (containing glycerin,
beta-mercaptoethanol, and SDS in Tris buffer) and boiled for five minutes in preparation for
electrophoresis. Bio-Rad precast 4–20% Tris-HCl gradient SDS-PAGE gels were run at 150 V
for 45 minutes. Gels were then stained with Bio-Rad Flamingo fluorescent stain and imaged
using a UVP PhotoDoc-It UV Imaging System (Upland, CA) followed by LC-MS/MS
as described.
Data analysis. MS/MS data were analyzed and matched to rat protein sequences in the
Swiss Prot and TrEMBL database, using the MASCOT 2.4 database search engine (Matrix
Science, UK) with carbamidomethyl as a fixed modification and oxidation as a single variable
modification. Mass window for the parent ions were set to 1.8 m/z and 0.4 m/z for MS/MS
data. The same spectra were searched using similar restrictions with the SpectrumMill algo-
rithm (Agilent) and alignments were merged and curated using Scaffold v3.6.4. A minimum
peptide-ion score cut-off was set at 9 in SpectrumMill and the presence of at least six consecu-
tive y- or b-ions was required. Alignments reported from Scaffold were restricted to a false dis-
cover rate of less than 1%, with peptide and protein confidence>90% and at least two unique
peptides required.
Network analysis. We used the MetaCore (MetaCore, GeneGO Inc., St. Joseph, MI, USA)
networking function and String database 9.1 to curate interaction maps of the proteins identi-
fied. Information for identified interactions is obtained from several sources including but not
limited to genomic context, database imports (PPI and pathway databases), high-throughput
experiments, co-expression, and text mining. We uploaded our lists of proteins from LC-MS/
MS into the software programs and exported the networks into Cytoscape 2.7.0 for manipula-
tion of the network appearance.
Co-immunoprecipitation
HEK293T[37] cells were transfected with Flag-PRICKLE1 or Flag-PRICKLE2 with Polyfect
(Qiagen), according to the manufacturer’s protocol. Cells were lysed in ice-cold NET-100 buff-
er after 48 hrs of incubation and immunoprecipitated overnight with anti-Flag beads at 4°C.
Beads were washed for 5 minutes x 5 times in ice-cold NET-100 buffer. Immunoprecipitates
were resolved by SDS-PAGE on a 4–20% gel and then subjected to anti-USP9X (1:500) immu-
noblot analysis. HRP-conjugated anti-rabbit secondary antibody was used at a 1: 2000 dilution.
For mapping studies, HEK293T cells transfected with Flag-PRICKLE1, Flag-NPRICKLE1 or
Flag-CPRICKLE1; Flag-PRICKLE2, Flag-NPRICKLE2 or Flag-CPRICKLE2 with Polyfect
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(Qiagen). Transfected cells were treated as described above. Lysates were also immunoprecipi-
tated overnight with anti-Flag beads, eluates resolved by SDS-PAGE and then subjected to
anti-USP9XWestern blot analysis. Membranes were stripped and reprobed with anti-BCR an-
tibodies (1:1000) overnight. HRP-conjugated anti-rabbit secondary antibody was used at a
1:10000 dilution. Blots were developed; and signals captured on X-ray films.
Ubiquitination/deubiquitination assays
Flag-PRICKLE1 only, Flag-PRICKLE1 + HA-UbiquitinC or Flag-PRICKLE1 + HA-Ubiqui-
tinC + mCherryC1Usp9x were transfected into HEK293T cells and incubated for 48 hours.
Cells were lysed and PRICKLE1 immunoprecipitated overnight via the Flag tag and resolved
by SDS-PAGE. Ubiquitinated and de-ubiquitinated PRICKLE1 was detected by anti-HA
(1:1000) Western blot analysis. The membrane was incubated in anti-HA-peroxidase at room
temperature for 2 hours and washed for 4 X 10 minutes in TBST. Blots were developed; and
signals captured on X-ray films. The process was repeated for PRICKLE2 where Flag-PRICK-
LE2 only, Flag-PRICKLE2 + HA-UbiquitinC or Flag-PRICKLE2 + HA-UbiquitinC + mCher-
ryC1Usp9x were transfected. The process was repeated with full-length USP9X with and
without the proteasome inhibitor LLNL (N-acetyl-L-leucyl-L-leucyl-L-norleucinal) at a con-






Mice subjects. All mouse work was done under ethical clearance from the Griffith Univer-
sity, and The Women’s and Children’s Health Network, and the South Australian Pathology
Department Animal Ethics Committees. All protocols used were in accordance with the policy
and guidelines of the National Health and Medical Research Council of Australia. Personnel
and investigators who handled the mice were properly trained and qualified. Animals were
treated humanely, discomfort and distress were minimized during the experiments and ani-
mals were monitored for signs of pain and distress. All euthanasia was performed using
cervical dislocation.
Human subjects. All human DNA samples were collected with proper informed consent
and with approval from an institutional review board (IRB).
Generation of Emx1-Cre mouse
To generate mice in which Usp9X was conditionally deleted from the dorsal telencephalon,
Usp9XloxP/loxP female mice were crossed with heterozygous Emx1-Cre males as described pre-
viously.8 Under this breeding regime, all male offspring receive a Usp9X loxP gene. Male off-
spring positive for Cre were used as Usp9X cKO and Cre negative male littermates were used
as controls.[12]
Mouse genotyping
Mouse genotyping was performed on DNA extracted from tail tips and PCR was performed
using RedExtract tissue PCR Kit (Sigma-Aldrich) as per the manufacturer’s instructions. Prim-
ers were designed to detect Cre-recombinase, F: CTGACCGTACACCAAAATTTGCCTG; R:
GATAATCGCGAACATCTTCAGGTTC. Male embryos were identified using primers for the
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SRY region of the Y chromosome, F: GAGGCACAAGTTGGCCCAGCA; R: GGTTCCTGT
CCCACTGCAGAAG.
Perfusion and Cryo-sectioning
Four-week old mice were anesthetized, perfused trans-cardially with 4% paraformaldehyde
(PFA), then heads were drop-fixed in 4% PFA. Following fixation brains were cryo-protected
in 15% sucrose at 4°C overnight, then in 30% sucrose at 4°C overnight, 1:1 ratio of 30% sucrose
and O.C.T at 4°C overnight and frozen in Tissue-Tek O.C.T. compound (Sakura), then sec-
tioned at 10 μm on a cryostat.
Immunohistochemistry
The coronal mouse brain sections were permeabilised in 1% sodium dodecyl sulphate (SDS) in
1X PBS for 4 minutes at room temperature. After washing 3 times with PBS, the samples were
blocked in 2% Bovine serum albumin (BSA) in 1X PBS for 20 minutes, incubated with rabbit
anti-Prickle2 antibody at 1/250 dilution in 2% BSA/PBS at 4°C overnight, then incubated with
1/200 dilution of goat anti-rabbit biotinylated antibody (Invitrogen) in 2% BSA/PBS for 1h and
in 1/400 streptavidin-biotin-peroxidase complex (Invitrogen) in 2% BSA/PBS for 1h at room
temperature, and mounted with Vectashield mounting medium with DAPI (Vector Laborato-
ries). Images were obtained on Olympus FV1000 confocal microscope.
Fly lines
Oregon-R (OR) and outcrossed prickle-spiny-legs (pksple) lines are referred to in Ehaideb et al.
[3] fat facets (faf) lines were obtained from the Bloomington Drosophila Stock Center at Indi-
ana University (line numbers 25100 (w[]; st1 fafB3/TM6B, Tb1), 25101 (w[]; st1 fafBX3/TM6B,
Tb1), 25107 (w[]; st[1] faf[BX4]/TM6B, Tb[1])).
Modified bang-sensitivity behavioral assay
As previously described[3].
Drug treatment
Newly eclosed flies were collected and maintained on standard fly food for two days. On the
third day, flies were starved for 6 hours by placing them in glass vials containing damp cotton.
Three vials of each genotype were then transferred to vials containing 4 ml of standard fly food
mixed with 40 μl of 100 mMDegrasyn (final concentration 1 mM;WP1130, Selleck Chemicals)
and aged until the flies were 7 days old, before subjecting them to the fly-flip assay. Each vial
contained*10 flies (5 males and 5 females) maintained at 25 degrees C.
“Fly flip” seizure assay
Seven-day old flies were transferred to an empty vial and the vial Flug (fly plug; Flystuff.com)
was pushed downward until a gap of 2 cm (from the bottom of the vial to the Flug) was created,
preventing flies from moving out of camera frame in order to keep track of individual flies. Six
vials of flies of each genotype were then mechanically stimulated with a vortex mixer (Fisher
Scientific Vortex Mixer; maximal setting of 10) for 5 seconds. After vortexing, flies were digital-
ly recorded for 1 minute (from the start of the vortex); only flies that flipped on their back and
remained at that position for at least one second were considered flies exhibiting muscle-jerk
seizure activity. Tester was blinded to genotype for all tests. Flies were randomly sorted into
placebo versus drug group.
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Targeted resequencing of USP9X
We captured all USP9X exons and at least five base pairs of flanking sequence using molecular
inversion probes, and performed next generation sequencing and data analysis as described
previously.[39] Our resequencing cohort consisted of 284 males diagnosed with epileptic en-
cephalopathy according to the International League Against Epilepsy (ILAE) classification cri-
teria.[40] We considered only non-synonymous, frameshift or splice-site mutations that were
rare (<2%) in the ESP6500 data set (see web resources) for further analysis. Segregation analy-
sis using Sanger sequencing was performed where possible for variants that met these criteria,
and paternity/maternity confirmed using the PowerPlex S5 system [Promega].
Characterization of USP9X variants in the exome variant server. USP9X variants were
downloaded from the EVS website. Rare (<2%), hemizygous (male), non-synonymous variants
considered damaging or possibly damaging by Polyphen were tabulated for the combined Eu-
ropean-American and African-American populations and used for statistical analysis. In addi-
tion, one frameshift mutation not qualified by polyphen was included, for a total of four
damaging protein-changing variants.
Protein accession numbers
Human-USP9X: Accession: NP_001034679.2 GI: 145309309, mouse-Usp9x; NP_033507.2 GI:
115511018; human-PRICKLE1 NP_001138354.1 GI: 23308518; human-PRICKLE2
NP_942559.1_GI: 38524620; Drosophila prickle NM_165508.2 GI: 442622668.
Statistics
To assess statistically enrichment for USP9X coding variants in the epilepsy cohort, a one-tailed
chi-square test without Yates correction was performed using the number of mutant and wild-
type alleles from male epilepsy patients and EVS male populations. For the EVS counts, the av-
erage number of individuals genotyped per variant in the database was used as the total geno-
type count in the chi-square test. Student’s t-tests were employed for the Drosophila ‘fly flip’
and modified bang sensitivity assays. Power to detect variants for both the human cohort and
the fly assays was based on our previously published studies.[5]
Supporting Information
S1 Fig. Usp9x is a novel PRICKLE binding partner. A. Stably transfected PC12 cell lines indu-
cibly express GFP. Doxycycline induction of GFP (Panel II) and differentiation in the presence of
NGF after a 72-hr incubation period (Panel III). B.Anti-GFPWestern blot shows PC12 cells ex-
pressing GFP, GFP-PRICKLE1 or GFP-PRICKLE2, under the control of tetracycline (doxycy-
cline)-inducible promoters. C. Silver staining shows expressed transgenes and associating
proteins in GFP, GFP-PRICKLE1, and GFP-PRICKLE2 immunoprecipitates fromNGF-differ-
entiated PC12 cell lines. Arrows point to GFP, GFP-PRICKLE1, and GFP-PRICKLE2 proteins.
(TIFF)
S2 Fig. Mass spectrometry identifies interacting proteins (individual dots) in immunopre-
cipitates. Scatter plot shows both slopes of regressions are both over 1 (1.75 and 1.32 for
PRICKLE1 and PRICKLE2 respectively), indicating that both GFP-PRICKLE1 and PRICKLE2
PC12 cell lines had more peptide hits than the GFP control for most proteins. The correlation
coefficients for both PRICKLE1 and PRICKLE2 were less than 1 (0.85 and 0.34 respectively)
indicating differences between PRICKLE proteins and the GFP control.
(TIFF)
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S3 Fig. PRICKLE is polyubiquitinated and degraded by the proteasome. A,B. Anti-Flag im-
munoprecipitates from HEK293T cells transiently overexpressing the indicated plasmids and
increasing dosage of C1Usp9x shows increasing dosage of the C1Usp9x is associated with in-
creasing deubiquitination of PRICKLE. Anti-Flag WB shows increasing stabilization of
PRICKLE with increasing C1Usp9x-mediated deubiquitination. C,D. PRICKLE1 or PRICK-
LE2 transfected with the indicated constructs in the presence and absence of the proteasome
inhibitor LNLL (50μm) shows accumulation of polyubiquitinated PRICKLE with
LLNL treatment.
(TIFF)
S1 Table. With peptide hits of>10, 11 proteins were found that specifically interacted with
PRICKLE (PK) but not the GFP control from PC12 immunoprecipitates. Tanc and Bcr
have previously been identified6 while Usp9x and the others listed are novel.
(DOCX)
S2 Table. Numbers of rare variants found in epileptic encephalopathy cohort vs. EVS males
in the combined European and African American population (p-value<0.05) indicate an asso-
ciation of USP9X with epilepsy in humans.
(DOCX)
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